Key Highlights
- The Finnish wearable technology company has kicked off its U.S. IPO roadshow with ambitions to secure up to $2.2 billion in funding.
- Oura intends to offer 50 million shares with a pricing window of $40 to $44 per share.
- If priced at the upper end, the company would achieve a fully diluted market capitalization of approximately $15.6 billion.
- The firm reported revenue of $1.21 billion for the nine-month period concluded June 30, marking a 74% year-over-year increase.
- Trading under the ticker symbol OURA on Nasdaq is anticipated to commence following next week’s pricing.
The wearable health technology company Oura has commenced its initial public offering process, aiming to secure as much as $2.2 billion from American investors. The firm is offering 50 million shares within a $40 to $44 price bracket.
Should the offering price at its maximum, Oura would command a fully diluted market value of roughly $15.62 billion. The company has submitted its application for a Nasdaq listing, where it will trade under OURA.
Strong Revenue Performance Driven by Device Demand
For the nine-month stretch ending June 30, Oura recorded approximately $1.21 billion in total revenue, representing a substantial 74% climb compared to the corresponding timeframe in the prior year. The year-ago period generated revenues near $697 million.
The company has witnessed impressive momentum in hardware distribution. According to filing documents, Oura distributed 3.6 million smart rings throughout the 12-month window ending June 30.
During just the nine months concluded June 30, Oura shipped 4.1 million rings, more than doubling the 1.8 million units sold in the equivalent period one year prior. The firm disclosed a net loss of $924 million across that nine-month timeframe.
The latest Oura Ring 5 model carries a retail price spanning $399 to $499. This wearable device monitors various health indicators such as sleep patterns, physical activity levels, daily readiness scores, stress measurements, cardiovascular metrics, and reproductive health data.
Distinguishing itself from conventional smartwatches, the Oura Ring features no display screen. This design choice enables the device to maintain approximately seven days of battery life while delivering around-the-clock health monitoring capabilities.
Membership Program Drives Recurring Revenue Stream
Beyond hardware sales, Oura cultivates ongoing revenue through its membership program, priced at $5.99 monthly. As of June 2026, the subscription service had attracted 5 million paying subscribers.
Management forecasts that fiscal 2026 will conclude with roughly 5.7 million paid subscribers. This projection would signify approximately 96% growth versus the prior fiscal year.
The user demographic shows that women comprise about 72% of Oura’s membership, while individuals aged 45 and above account for 27%. The company faces competition from established players including Apple, Fitbit, Samsung, and Whoop in the wearables space.
Smart rings have carved out a distinctive niche within the broader wearables industry by delivering compact, display-free health monitoring solutions. Samsung has also ventured into this product category with its competing smart ring offering.
Major Investors Signal Strong Demand for Offering
The public offering has generated noteworthy attention from substantial potential backers. Pharmaceutical giant Eli Lilly has expressed potential interest in acquiring up to $100 million worth of shares during the IPO.
Dragoneer Investment Group has similarly signaled willingness to purchase as much as $300 million in stock. It should be noted that these preliminary indications don’t constitute binding commitments for the stated purchase amounts.
This offering will function as a barometer for investor appetite toward consumer technology public listings following a relatively muted autumn IPO calendar. Recent market conditions have been influenced by elevated Treasury yields, shifting Federal Reserve policy expectations, and valuation concerns surrounding technology companies.
In a private financing round conducted last year, Oura secured a valuation around $11 billion. An IPO valuation of $15.62 billion would mark meaningful appreciation should the offering achieve pricing at its targeted high end.
Goldman Sachs, Morgan Stanley, and JPMorgan serve as lead underwriters for the transaction. Oura anticipates completing pricing procedures and initiating Nasdaq trading operations during the upcoming week.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
